GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to ...

Pharmaceutical REMS Market SizeThe global pharmaceutical REMS market — a critical safety framework for high‑risk drugs — is ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...

"Inside the explosive rise of a wellness company outpacing a $200B+ global market"Watch the full Morning Show interview → ...

Lung Cancer Diagnostics Market OverviewThe global lung cancer diagnostics market is undergoing significant expansion as healthcare systems, technology developers, and research institutions intensify ...

US agreement removes U.S. tariffs on UK drugs but requires the NHS to pay more for new medicines by raising NICE thresholds ...

The gene editing market is experiencing significant growth, with a projected annual growth rate (CAGR) of 16-18% in the coming years. This expansion is fueled by breakthroughs in gene-editing ...

Daemon is excited to announce it is a recipient of a 2025 Geography and Global AWS Partner Award, recognising leaders around the globe that are playing key roles in helping their customers drive ...

Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF ...

SIOUX FALLS, SD / ACCESS Newswire / December 2, 2025 / Avel eCare is pleased to announce the appointment of Pat Gundersen as its new Chief Revenue Officer, bringing more than twenty years of ...

Ideagen's CEO explains why binary outcomes and high stakes make compliance ideal for autonomous AINOTTINGHAM, ...

This is the first agreement signed by the EIB with a corporate venture capital in the healthcare sector, and is part of the EU strategy to support the development of innovative companies across the ...